Provided by Tiger Fintech (Singapore) Pte. Ltd.

HUTCHMED

24.160
-0.040-0.17%
Volume:1.11M
Turnover:26.62M
Market Cap:21.07B
PE:70.48
High:24.200
Open:24.000
Low:23.840
Close:24.200
52wk High:30.750
52wk Low:18.360
Shares:872.00M
HK Float Shares:872.00M
Volume Ratio:1.60
T/O Rate:0.13%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.343
ROE:46.90%
ROA:-0.81%
PB:2.21
PE(LYR):70.48
PS:4.50

Loading ...

HUTCHMED (00013) to Present FRUSICA-2 Registration Study Data at 2025 European Society for Medical Oncology Annual Meeting

Stock News
·
Oct 13

HUTCHMED Announces Positive FRUSICA-2 Trial Results for Fruquintinib and Sintilimab Combo in Advanced Renal Cell Carcinoma; Data to Be Presented at 2025 ESMO Congress

Reuters
·
Oct 13

Hong Kong Stock Announcements | YUNFENG FIN: Strategic Investment in Global Cryptocurrency Life Insurance Company Anthea and Strategic Cooperation

Stock News
·
Oct 02

HUTCHMED (00013) to Present Clinical Data at 2025 European Society for Medical Oncology (ESMO) Annual Conference

Stock News
·
Oct 02

HUTCHMED Announces New Clinical Data to Be Presented at ESMO Congress 2025, Highlighting Advancements in Oncology Therapies

Reuters
·
Oct 02

HUTCHMED (China) Cut to Underweight From Equal-Weight by Morgan Stanley

Dow Jones
·
Sep 23

HUTCHMED (00013) to Present Latest R&D Progress on October 31

Stock News
·
Sep 12

HUTCHMED (China) Ltd. to Present Key R&D Updates at Upcoming Shanghai Event

Reuters
·
Sep 12

Save the Date: HUTCHMED to Present R&D Updates on October 31, 2025

GlobeNewswire
·
Sep 12

Hong Kong Stock Movement | Innovative Drug Stocks Rise Across the Board as 2025 World Lung Cancer Congress Approaches, Institutions Bullish on Valuation Recovery Potential of Innovative Drug Sector

Stock News
·
Sep 05

Hong Kong Stock Movement | HUTCHMED (00013) Surges Over 5% as Company to Present Latest Data on Self-Developed Compounds at 2025 WCLC and CSCO Conferences

Stock News
·
Sep 05

HUTCHMED (00013) to Present Latest Data from Multiple Proprietary Compound Studies at 2025 World Conference on Lung Cancer and CSCO 2025 Annual Conference

Stock News
·
Sep 05

HUTCHMED Announces Presentation of New Clinical Data on Savolitinib at 2025 World Conference on Lung Cancer

Reuters
·
Sep 05

Hong Kong Stock Movement | Innovative Drug Concept Stocks See Expanding Declines as Trump Announces Swift Pharmaceutical Tariffs, Morgan Stanley Expects Low Likelihood of BD Taxation

Stock News
·
Aug 26

Hutchmed Names Johnny Cheng Acting CEO

MT Newswires Live
·
Aug 25

Hutchmed Names CFO as Acting CEO

MT Newswires Live
·
Aug 25

BRIEF-Hutchmed (China) Says Weiguo Su Takes Leave As CEO Due To Health Reasons

Reuters
·
Aug 25

HUTCHMED (00013): Executive Director and CFO Zheng Zefeng Appointed as Interim CEO

Stock News
·
Aug 25

HUTCHMED (China) Ltd - Weiguo SU Takes Leave as CEO Due to Health Reasons

THOMSON REUTERS
·
Aug 25

HUTCHMED (China) Ltd - Johnny Cheng Appointed Acting CEO of HUTCHMED

THOMSON REUTERS
·
Aug 25